Hashino S - Search Results

1

Reduced intensity conditioning regimen with fludarabine, busulfan, and low-dose TBI (Flu-BU2-TBI): clinical efficacy in high-risk patients.

Takahata M, Hashino S, Okada K, Onozawa M, Kahata K, Sugita J, Shigematsu A, Kondo T, Yamamoto S, Endo T, Nishio M, Ito YM, Tanaka J, Koike T, Asaka M, Imamura M. Takahata M, et al. Among authors: hashino s. Am J Hematol. 2010 Apr;85(4):243-8. doi: 10.1002/ajh.21630. Am J Hematol. 2010. PMID: 20162540 Free article.

2

Successful second allogeneic bone marrow transplantation in a relapsed acute myeloid leukemia patient with fungal liver abscess.

Tanaka J, Kasai M, Masauzi N, Watanabe M, Matsuura A, Morii K, Kiyama Y, Naohara T, Higa T, Hashino S, et al. Tanaka J, et al. Among authors: hashino s. Ann Hematol. 1992 Oct;65(4):193-5. doi: 10.1007/BF01703114. Ann Hematol. 1992. PMID: 1384722

3

Toxicity of high-dose busulfan and cyclophosphamide as a preparative regimen for bone marrow transplantation.

Kasai M, Kiyama Y, Watanabe M, Seto K, Matsuura A, Tanaka J, Takeda H, Naohara T, Higa T, Hashino S, et al. Kasai M, et al. Among authors: hashino s. Transplant Proc. 1992 Aug;24(4):1529-30. Transplant Proc. 1992. PMID: 1496647 No abstract available.

4

In vivo administration of cytokine in allogeneic bone marrow chimeras.

Imamura M, Fujimoto H, Hashino S, Fukuhara T, Kobayashi M, Kasai M, Sakurada K, Miyazaki T. Imamura M, et al. Among authors: hashino s. Immunobiology. 1990 Jun;180(4-5):441-57. doi: 10.1016/S0171-2985(11)80305-0. Immunobiology. 1990. PMID: 1697845

5

[The control of GVHD and immunodeficiency].

Imamura M, Hashino S. Imamura M, et al. Among authors: hashino s. Rinsho Ketsueki. 1991 Apr;32(4):372-5. Rinsho Ketsueki. 1991. PMID: 2067081 Review. Japanese.

6

Suppressor activity in the supernatant of T cell clones derived from chimeric mouse spleen cells.

Imamura M, Fujimoto H, Fukuhara T, Kobayashi M, Hashino S, Kasai M, Sakurada K, Miyazaki T. Imamura M, et al. Among authors: hashino s. Immunobiology. 1988 Apr;177(1):91-103. doi: 10.1016/S0171-2985(88)80095-0. Immunobiology. 1988. PMID: 2454880

7

Non-specific suppressor cells in murine bone marrow chimeras: their possible role in GVHD-associated immunodeficiency.

Imamura M, Fujimoto H, Fukuhara T, Kobayashi M, Hashino S, Kasai M, Sakurada K, Miyazaki T. Imamura M, et al. Among authors: hashino s. Immunobiology. 1988 Feb;176(3):313-27. doi: 10.1016/S0171-2985(88)80061-5. Immunobiology. 1988. PMID: 2966105

8

In vivo effects of the immunosuppressant 15-deoxyspergualin on hematopoiesis in murine allogeneic bone marrow chimeras. Its thrombopoietic activity and reversal of adverse effects with granulocyte colony-stimulating factor and/or erythropoietin.

Imamura M, Han M, Hashino S, Kobayashi H, Imai K, Kobayashi S, Tanaka J, Zhu X, Kobayashi M, Fujii Y, et al. Imamura M, et al. Among authors: hashino s. Transplantation. 1994 Jul 27;58(2):214-23. Transplantation. 1994. PMID: 7518976

9

Soluble c-kit levels in acute GVHD after allogeneic bone marrow transplantation.

Hashino S, Imamura M, Kobayashi S, Tanaka J, Kasai M, Sakurada K, Asaka M. Hashino S, et al. Br J Haematol. 1995 Apr;89(4):897-9. doi: 10.1111/j.1365-2141.1995.tb08431.x. Br J Haematol. 1995. PMID: 7539626

10

bcr-abl hybrid messenger RNA in a patient with Philadelphia-negative essential thrombocythemia.

Hashino S, Imamura M, Kobayashi S, Kunieda Y, Kobayashi H. Hashino S, et al. Acta Haematol. 1995;94(1):52-4. doi: 10.1159/000203972. Acta Haematol. 1995. PMID: 7544525

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

207 results

Search Page

Filters